Your account has been succesfully created.

Italy, Russia, Switzerland
RDIF calls on Italian-Swiss contacts to secure Sputnik V production

Reading time 2 min

Head of the Russian Direct Investment Fund Kirill Dmitriev.
Head of the Russian Direct Investment Fund Kirill Dmitriev. © Reuters

While the European Union is still divided over Russia's Sputnik V vaccine, Moscow's sovereign wealth fund is working its contacts with European pharmaceutical groups, starting with Antonio di Naro's Swiss group Adienne, with the view towards future production.

Read also

On our other sites

Sign up for real-time alerts and be notified of new editions!  

Once registered, you will be notified by a short message on your computer or mobile phone as soon as a new edition of our publication or an alert is published. Stay informed anytime, anywhere!